000 01300 a2200361 4500
005 20250513071509.0
264 0 _c19940222
008 199402s 0 0 eng d
022 _a0954-6111
024 7 _a10.1016/s0954-6111(05)80261-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSheldon, C D
245 0 0 _aRegular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa.
_h[electronic resource]
260 _bRespiratory medicine
_cNov 1993
300 _a587-93 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aChronic Disease
650 0 4 _aCiprofloxacin
_xadministration & dosage
650 0 4 _aCystic Fibrosis
_xcomplications
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOpportunistic Infections
_xcomplications
650 0 4 _aPseudomonas Infections
_xdrug therapy
700 1 _aAssoufi, B K
700 1 _aHodson, M E
773 0 _tRespiratory medicine
_gvol. 87
_gno. 8
_gp. 587-93
856 4 0 _uhttps://doi.org/10.1016/s0954-6111(05)80261-6
_zAvailable from publisher's website
999 _c8290022
_d8290022